Greater Cannabis To Present at the Benzinga Cannabis Capital Conference
Greater Cannabis Co. (OTC: GCAN) announced that CEO Aitan Zacharin will present at the Benzinga Virtual Cannabis Investor Conference on February 26th at 10:35 AM EST. The presentation will last approximately 20 minutes and will cover an overview of the company's business, technology, and recent progress. GCAN encourages both individual and institutional investors to attend using a free spectator pass available online.
The company specializes in developing innovative cannabinoid delivery systems aimed at enhancing patient experience and efficacy.
- None.
- None.
BALTIMORE, MD, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Co. (OTC: GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products is pleased to announce that Mr. Aitan Zacharin, GCAN Chief Executive Officer, will be presenting at the Benzinga Virtual Cannabis Investor Conference on February 26th at 10:35am EST on Track 1.
Mr. Zacharin will provide the virtual audience with an overview of the GCAN business and technology, and a corporate update about the Company’s progress.
The presentation will run for roughly 20 minutes. GCAN invites individual and institutional investors, as well as advisors and analysts, to attend the presentations with a free spectator pass at https://events.benzinga.com/squeeze-page-422415971607984646162
About The Greater Cannabis Company
The Greater Cannabis Company (GCAN) is a fully reporting publicly traded biopharmaceutical company focused on the development and commercialization of innovative cannabinoid delivery systems. Greater Cannabis deploys its technology platform for use in the cannabis industry. The Company’s conveyance platform can be utilized to deliver cannabinoids without the harmful side effects found with other routes of cannabinoid administration. The technology is versatile in that patients can now receive lower dosing, enhanced bioavailability, and controlled rapid and delayed release using non-irritant oral eluting and transdermal patches. Greater Cannabis’ mission is to bring our technology to the global market through partnerships with leading cannabis and pharmaceutical companies, for the benefit of patients and consumers. More information on the Greater Cannabis Company and its technology can be found on the Company’s website, www.gcanrx.com.
About Benzinga Capital Conference
Benzinga is a leading financial media company dedicated to making information easier to consume. Benzinga's news desk is constantly breaking stories and moving billions of dollars of market capitalization through its real-time news tool, Benzinga Pro. Benzinga's original content is syndicated to 70 partner websites including Yahoo! Finance MSN, CNNMoney, Fox Business and MarketWatch. The Benzinga Cannabis Capital Conference is the premier gathering of Cannabis Entrepreneurs and investors in North America. No other conference offers the level of access and seamlessness of interaction between entrepreneurs building future billion-dollar cannabis enterprises and the investors whose capital will make that happen.
Greater Cannabis Co. Disclaimer: Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve a high degree of risk and uncertainty, are predictions only and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to differences include the uncertainty regarding viability and market acceptance of the Company's products and services, the ability to complete development plans in a timely manner, changes in relationships with third parties, product mix sold by the Company and other factors described in the Company's most recent periodic filings with the Securities and Exchange Commission, including its 2019 Annual Report on Form 10-K and quarterly reports on Form 10-Q.
Forward-Looking Statements: This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions.
These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential, "predict," "project," "should," "would" and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company's filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact: The Greater Cannabis Company, Inc.
443-738-4051
info@gcanrx.com
www.gcanrx.com
FAQ
When will Greater Cannabis Co. present at the Benzinga Virtual Cannabis Investor Conference?
Who will represent GCAN at the Benzinga conference?
What will GCAN's presentation cover?
How long is the GCAN presentation scheduled for?
How can investors attend the GCAN presentation?
What is the purpose of the Benzinga Virtual Cannabis Investor Conference?
